Manini MA, Bruce M, Whitehouse G, Mazzarelli C, et al. A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients. Transplant Proc 2020 Jun 28. pii: S0041-1345(19)31356.
PMID: 32605776